Clinically Meaningful Improvements in St George's Respiratory Questionnaire Score with Tezepelumab Versus Placebo in Patients with Severe, Uncontrolled Asthma: Results from the Phase 3 NAVIGATOR Study

被引：0
|
作者：
Kraft, M. [1 ]
Corren, J. [2 ]
Ambrose, C. S. [3 ]
Cook, B. [3 ]
Clarke, N. [4 ]
Hunter, G. [5 ]
Molfino, N. [6 ]
Ponnarambil, S. [7 ]
机构：
[1] Univ Arizona, Hlth Sci Ctr, Tucson, AZ USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[3] AstraZeneca, Resp & Immunol, BioPharmaceut Med, Gaithersburg, MD USA
[4] AstraZeneca, Patient Centered Sci, Resp & Immunol, Gaithersburg, MD USA
[5] AstraZeneca, Late Stage Dev, Resp & Immunol, BioPharmaceut R&D,Biometr, Cambridge, England
[6] Amgen Inc, Global Dev, Thousand Oaks, CA USA
[7] Astrazeneca, Late Stage Dev Resp & Immunol, BioPharmaceut R&D, Cambridge, England
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2022年 / 205卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A2360
引用
收藏
页数：2
相关论文
共 50 条
  • [31] The effect of tezepelumab in patients with allergic and non-allergic asthma: results from the NAVIGATOR phase 3 study
    Corren, J.
    Menzies-Gow, A.
    Ambrose, C. S.
    Cook, B.
    Kmita, K.
    Colice, G.
    Llanos-Ackert, J.
    [J]. ALLERGY, 2021, 76 : 13 - 14
  • [32] Tezepelumab Efficacy by SNOT-22 Domain Scores in Patients With Severe, Uncontrolled Asthma and Comorbid Nasal Polyps in the Phase 3 Navigator Study
    Spahn, J. D.
    Jacobs, J. S.
    Hoyte, F.
    Ambrose, C. S.
    Martin, N.
    Vong, S.
    Caveney, S.
    Cook, B.
    Colice, G.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [33] On-treatment clinical remission with tezepelumab in patients with severe, uncontrolled asthma in the phase 3 DESTINATION study
    Wechsler, Michael E.
    Brusselle, Guy
    Virchow, J. Christian
    Heaney, Liam G.
    Hunter, Gillian
    Ponnarambil, Sandhia
    Martin, Neil
    Llanos, Jean-Pierre
    Porsbjerg, Celeste
    Brightling, Christopher E.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [34] ON-TREATMENT CLINICAL REMISSION WITH TEZEPELUMAB IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA IN THE PHASE 3 DESTINATION STUDY
    Wechsler, M. E.
    Brusselle, G.
    Virchow, J. C.
    Heaney, L. G.
    Hunter, G.
    Ponnarambil, S.
    Martin, N.
    Llanos, J-P
    Porsbjerg, C.
    Brightling, C. E.
    [J]. THORAX, 2023, 78 (SUPPL_4) : A272 - A273
  • [35] The proportions of tezepelumab-treated patients with severe, uncontrolled asthma who achieved twice the minimum clinically important difference in patient-reported outcome measures in the phase 3 NAVIGATOR study
    不详
    [J]. ALLERGY, 2023, 78 : 3 - 3
  • [36] Incidence Of Infections In Patients With Severe, Uncontrolled Asthma Treated With Tezepelumab: A Pooled Analysis Of The Phase 2b PATHWAY And Phase 3 NAVIGATOR Studies
    Menzies-Gow, Andrew
    Corren, Jonathan
    Ambrose, Chris
    Hunter, Gillian
    Fitzpatrick, Sherahe
    Hagberg, Anette
    Ponnarambil, Sandhia
    Martin, Neil
    Molfino, Nestor
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB16 - AB16
  • [37] Efficacy of Tezepelumab in Patients with Moderate-to-Severe, Uncontrolled Asthma: A Pooled Analysis of the Phase 2b PATHWAY and Phase 3 NAVIGATOR Studies
    Ambrose, Chris
    Menzies-Gow, Andrew
    Cook, Bill
    Hellqvist, Asa
    Roseti, Stephanie
    Molfino, Nestor
    Llanos-Ackert, Jean-Pierre
    Colice, Gene
    Corren, Jonathan
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB16 - AB16
  • [38] Efficacy of Tezepelumab in Patients with Moderate-to-Severe Uncontrolled Asthma: A Pooled Analysis of the Phase 2b PATHWAY and Phase 3 NAVIGATOR Studies
    Corren, J.
    Menzies-Gow, A.
    Ambrose, C.
    Cook, W.
    Hellquist, A.
    Roseti, S.
    Molfinao, N.
    Lanos-Ackert, P. J.
    Colice, G.
    [J]. PNEUMOLOGIE, 2022, 76 : S14 - S14
  • [39] Impact of exacerbations on St George's Respiratory Questionnaire score in patients with severe asthma: post hoc analyses of two clinical trials and an observational study
    Nelsen, Linda M.
    Cockle, Sarah M.
    Gunsoy, Necdet B.
    Jones, Paul
    Albers, Frank C.
    Bradford, Eric S.
    Mullerova, Hana
    [J]. JOURNAL OF ASTHMA, 2020, 57 (09) : 1006 - 1016
  • [40] Seasonal Variability of Exacerbations in Patients with Severe, Uncontrolled Asthma and Clinical Benefits of Tezepelumab: Results from the PATHWAY Phase 2b Study
    Corren, J.
    Karpefors, M.
    Hellqvist, A.
    Parnes, J. R.
    Colice, G.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
12345